What Blood Cancer Patients Need To Know
(NAPSI)—If you or someone you know has ever had blood cancer, a term you might have heard is “minimal residual disease,” or MRD. MRD refers to the small number of cancer cells that can stay in the body during and after treatment. Often, these cells are present at such low levels they do not cause any physical signs or symptoms. However, they may be a sign that cancer is returning.
As one of the strongest predictors of patient outcomes in blood cancer, MRD status can help you and your doctor understand how your body is responding to treatment and how it may change over time. When your MRD status shifts, you may find that the course of your blood cancer journey changes as well.
clonoSEQ® is an FDA-cleared test used to detect MRD in bone marrow from patients with multiple myeloma or B-cell acute lymphoblastic leukemia (B-ALL) and blood or bone marrow from patients with chronic lymphocytic leukemia (CLL). Testing is ordered by your doctor and performed by a licensed lab. clonoSEQ can detect very low levels of MRD—one cancer cell among a million cells (provided sufficient sample input)—so you and your doctor can be confident in your MRD status and prepared to act quickly if the cancer returns.
Talk to your doctor. If you have a blood cancer, talk with your care team about your MRD status to pinpoint where you are with your disease and develop a plan that works for you. To find a specialist and learn more, visit clonoSEQ.com and ask your doctor if clonoSEQ MRD testing is right for you.
Routine MRD testing may help detect the return of cancer before physical signs and symptoms arise. Knowing your MRD status can help you move forward with confidence when planning for all of life’s moments.
clonoSEQ is available by prescription use only. For more important information about the FDA-cleared uses of clonoSEQ, including sample types and test limitations, visit clonoSEQ.com/technical-summary.
On the Net:North American Precis Syndicate, Inc.(NAPSI)
Get Top Stories Delivered Weekly
Recent thenewsargus News Articles
Discuss This Article
MOST POPULAR THENEWSARGUS
WSSU Rams Head Football Coach Relieved of His Duties By Elijah Richardson
Bennett College Loses Accreditation Despite Raising Sufficient Funds By Elijah Richardson
Smollett Investigation Continues To Be Unsolved and Difficult to Resolve By Elijah Richardson
Lady Rams look to reverse an abysmal 2014-2015 season By Demetrius Dillard
GET TOP STORIES DELIVERED WEEKLY
LATEST THENEWSARGUS
- Black Business
- WSSU Rams Head Football Coach Relieved of His Duties
- Controversial Wake Forest Tweet Sparks Outrage
- Bennett College Loses Accreditation Despite Raising Sufficient Funds
- Smollett Investigation Continues To Be Unsolved and Difficult to Resolve
- UREC Looks To Continue and Improve Student Engagement Through Physical...
- University Recreation To Hold Personal Training Pilot Study
FOLLOW OUR NEWSPAPER
RECENT THENEWSARGUS CLASSIFIEDS
OUTSIDE THE LINES
- A Story To Sing About
- The Gap in Gum Care: Why Caring For Your Teeth’s F...
- Top Tips for Signature Scents and Better-Smelling Laundry
- A Dog Trainer’s Top Tips to Support Pets Through Life S...
- Clear the Air of Indoor Pollutants This Spring
- Stroke & Dementia in Black Men: Tips for Staying Healthy...
- Hispanics and African Americans at Higher Risk for Eye...
- African Americans at Higher Risk for Eye Disease
- Infinity Kings: Final Book In A Favorite Fantasy Series
- What You Need To Know About Keratoconus and the iLink...
FROM AROUND THE WEB
- No Child is Forgotten By Marine Toys for Tots
- Sweeten Your Springtime Salads With Healthy Chilean Grapes
- Young Author Translates 4,000-Year-Old Text to Reveal...
- Keeping Cool and Energy-efficient Amid America’s “...
- Addressing Sarcopenia with a Healthy Diet
- Subway’s New Wraps Elevate Eating on the Go
- Family Teacher Conference Topics Beyond Academics
- Youth Take Down Tobacco
- BookTrib’s Bites: Four Reads to Kickoff Spring
- Curbing Colorectal Cancer in Minority Populations